塩酸アロチノロール製剤の品質評価―先発医薬品と後発医薬品の比較―:―先発医薬品と後発医薬品の比較―
スポンサーリンク
概要
- 論文の詳細を見る
We evaluated the quality of the branded product (two presentations : 5 and 10 mg) and generic versions (nine products : one of them 5 mg and the other eight 10 mg) of arotinolol hydrochloride through dissolution, purity, content, and content uniformity tests. The results of an estimation of dissolution characteristics based on the quality reevaluation procedure showed that the dissolution characteristics of six products differed from those at the time of the quality reevaluation. Furthermore, differences in dissolution characteristics between production lots were observed for two products, suggesting that there may be products showing variation in quality on the market. However, our results showed that none of the products had quality—related problems as regards content and content uniformity for individual tablets or entire lots. They further indicated that the purity of seven generic products was equal to or higher than that of the branded product. Based on a comprehensive evaluation of the quality parameters we selected, the quality of one generic product was equal to or higher than that of the branded product.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)